Immatics (IMTX) Change in Accured Expenses (2019 - 2020)
Immatics recorded quarterly Change in Accured Expenses of -$8.8 million in Q4 2020, down 118.79% quarter-over-quarter from $46.7 million in Q4 2019, and down 118.79% year-over-year from $46.7 million in Q1 2020.
Immatics' Change in Accured Expenses history runs 2 years deep, the most recent figure standing at -$8.8 million for Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -8.78 Mn |
| Dec 31, 2020 | -8.78 Mn |
| Dec 31, 2019 | 46.71 Mn |
| Dec 31, 2019 | 46.71 Mn |